6533b838fe1ef96bd12a4548
RESEARCH PRODUCT
Is guideline-adherent adjuvant treatment an equivalent option for elderly patients who cannot participate in adjuvant clinical breast cancer trials? A retrospective multicenter cohort study of 4,142 patients.
Rolf KreienbergJochem KönigReyn Van EwijkAchim WöckelWolfgang JanniMaria BlettnerT GundelachLukas Schwentnersubject
Cancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGuidelinemedicine.diseaseSurgerylaw.inventionBreast cancerOncologyRandomized controlled triallawInternal medicinemedicinebusinessAdjuvantCohort studydescription
1063 Background: It is well accepted that innovation in oncology is transported through randomized clinical trials (CT). However, elderly patients (>65) are usually excluded from CT. Therefore this...
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2014-05-20 | Journal of Clinical Oncology |